Impact of Robot-assisted Radical Prostatectomy Technique on Short-term Continence Recovery
Launched by HENRY FORD HEALTH SYSTEM · Jan 27, 2015
Trial Information
Current as of July 03, 2025
Completed
Keywords
ClinConnect Summary
Traditionally, RARP is performed using a trans-peritoneal technique that pass anteriorly to the bladder. This technique necessitates the dissection and/or manipulation of many structures, which might compromise post-operative urinary continence recovery. These structures include the pubo-prostatic ligament, Santorini plexus, neurovascular bundle, and veil of Aphrodite. Recently, a "Retzius-sparing" technique to perform RARP has beed described. This approach passes posteriorly to the bladder, through the space of Douglas, which should minimize the damaged to the aforementioned structure. The...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • All patients with newly diagnosed prostate cancer undergoing robotic-assisted radical prostatectomy at the Vattikuti Urology Institute (performed by single surgeon, MM) as the primary treatment modality
- • Be able to read and speak English and be able to provide written informed consent
- Exclusion Criteria:
- • patients with high risk prostate cancer,defined as a biopsy Gleason score ≥8 and/or a pre-operative prostate specific antigen value ≥20 ng/ml.
- • evidence of clinical nodal involvement (cN1) or metastatic disease (M1)
- • patients participating in a competing study
- • patients with pre-operative urinary incontinence.
About Henry Ford Health System
Henry Ford Health System is a comprehensive, nonprofit healthcare organization based in Detroit, Michigan, renowned for its commitment to advancing medical research and patient care. With a robust network of hospitals, outpatient facilities, and specialty clinics, Henry Ford Health System is dedicated to innovation in clinical trials, focusing on translating scientific discoveries into effective treatments. The organization emphasizes multidisciplinary collaboration, leveraging its extensive resources and expertise to address diverse health challenges. Through its clinical research initiatives, Henry Ford Health System aims to enhance patient outcomes and contribute to the advancement of medical knowledge on both a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Detroit, Michigan, United States
West Bloomfield, Michigan, United States
Patients applied
Trial Officials
Mani Menon, MD
Principal Investigator
Henry Ford Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials